Manufacturing Execution Systems Market Outlook:
Manufacturing Execution Systems Market size was valued at USD 16.67 billion in 2025 and is likely to cross USD 48.19 billion by 2035, expanding at more than 11.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of manufacturing execution systems is assessed at USD 18.35 billion.
The growth in the market is primarily driven by the increasing popularity of automation in process and discrete production. According to a study published by ScienceDirect in June 2024, the adoption rate of Industry 4.0 technologies among global value chains (GVCs) worldwide ranged between 10.8% and 40.5%. This signifies the magnifying shift toward smart manufacturing and digital transformations to attain improved visibility and integrate real-time decision-making. Moreover, companies are deliberately seeking operational efficiency to reduce waste, escalate production yield, and ensure compliance by streamlining the whole procedure.
The enlarging pharmaceutical industry is also fueling adoption in the market. According to a report from the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), published in February 2025, the cost of constructing a new vaccine production site is calculated to be up to USD 2.0 billion. In addition, managing complex supply chains, ensuring sufficient production capacity, maintaining quality standards, and securing regulatory approvals for these plants require a significant investment. On the other hand, these advanced solutions replace paper-based procedures, which are too slow and prone to errors, assisting pharma producers with decreased downtime and risks, and allowing them to perform better and offer competitive payers’ pricing for their products.
